Clinical Trial

Antihistamine for Prevention of HTR After Blood Primed CPB

Study acronym: HTR - CPB
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study will be a randomized, double-blinded, placebo-controlled study conducted at a university hospital. Forty children undergoing elective repair of a congenital heart defect will be included. The patients will be randomly allocated (20 patients per group) to receive a single intravenous dose of combined chlorpheniramine or normal saline immediately after separation from CPB, before protamine administration.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-11.
Trial Details
NCT Number NCT07536152
Lead Sponsor Kasr El Aini Hospital
Collaborators: Misr University for Science and Technology
Conditions Blood Transfusion Associated Adverse Reactions
Enrollment 40 participants
Start Date 2026-03-01
Primary Completion 2026-11 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-21